BH
Benjamin Hu, M.D.
Board of Directors, Nominating & Corporate Governance Committee, Audit Committee, Compensation Committee
Nexalin TechnologyTherapeutic Areas
Nexalin Technology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Nexalin Device | Insomnia | Pivotal Trial |
| NeuroCare® AI Platform | Care Delivery & Management | Launched |
Leadership Team at Nexalin Technology
MW
Mark White
President and Chief Executive Officer, Board of Directors
DO
David Owens, M.D.
Chief Medical Officer, Board of Directors, Scientific Advisory Board
JV
Justin Van Fleet
Chief Financial Officer
CS
Carolyn Shelton
EVP of Clinical, Quality & Regulatory Affairs
JP
John Patrick Claude
Director of Engineering, Research and Development
LB
Leslie Bernhard
Chairman of the Board, Nominating & Corporate Governance Committee Chairman, Audit Committee Chairman, Compensation Committee
AK
Alan Kazden
Board of Directors, Nominating & Corporate Governance Committee, Audit Committee, Compensation Committee Chairman